Consilium Wealth Advisory’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.05M Buy
104,958
+2,085
+2% +$160K 2.39% 12
2026
Q1
$7.94M Buy
102,873
+2,578
+3% +$201K 2.71% 10
2025
Q4
$7.81M Buy
100,295
+5,007
+5% +$392K 2.88% 10
2025
Q3
$7.44M Buy
95,288
+5,294
+6% +$410K 2.87% 10
2025
Q2
$6.96M Buy
89,994
+1,000
+1% +$76.2K 2.94% 11
2025
Q1
$6.81M Buy
88,994
+3,701
+4% +$279K 3.42% 8
2024
Q4
$6.37M Buy
+85,293
New +$6.48M 3.04% 9

Other funds holding BIV

Consilium Wealth Advisory's BIV Position: Q2 2026 in Review

Consilium Wealth Advisory increased its Vanguard Intermediate-Term Bond ETF (BIV) stake by 2% in Q2 2026, buying an estimated $160K and bringing the position to 104,958 shares worth $8.05M. The position accounts for 2.39% of the portfolio, ranked #12.

Consilium Wealth Advisory first reported a position in BIV in Q4 2024 and has held it in 7 quarters since. 1,024 funds tracked by Wall St. Rank hold BIV as of Q2 2026.

  • Consilium Wealth Advisory held 104,958 shares of Vanguard Intermediate-Term Bond ETF worth $8.05M as of Q2 2026.
  • Consilium Wealth Advisory bought 2,085 Vanguard Intermediate-Term Bond ETF shares in Q2 2026, an estimated $160K.
  • Vanguard Intermediate-Term Bond ETF made up 2.39% of Consilium Wealth Advisory's portfolio in Q2 2026, its #12 holding.
  • Consilium Wealth Advisory first reported a position in Vanguard Intermediate-Term Bond ETF in Q4 2024 and has held it in 7 quarters since.
  • 1,024 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2026.

Based on Consilium Wealth Advisory's 13F filing for Q2 2026, filed 11 Aug 2026.